We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An American nicotine drink being marketed as a cigarette substitute would only be sold with a prescription if it hit the shelves in Canada, according to Health Canada.
Enzon Pharmaceuticals, Inc. and Santaris Pharma A/S announced that the companies have entered into a collaboration to co-develop and commercialize a series of innovative RNA Antagonists based on Santaris Pharma's LNA (locked nucleic acid) technology and utilizing Enzon's oncology drug development expertise.
Drugmaker Bristol-Myers Squibb Co. Thursday said the federal government is conducting a criminal probe of a settlement that would allow the company to stave off generic competition for its best-selling product for years.
A federal court has ruled for King Pharmaceuticals in its suit against Lupin for infringing on its patent for the blood pressure drug Altace, King announced July 18.
Sen. Mike Enzi's (R-Wyo.) hearing to consider Andrew von Eschenbach's nomination as the next FDA commissioner will be used to pressure Democrats to drop their threat to prevent a Senate vote on it, numerous sources said.